Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrazines >  3-BROMOIMIDAZO[1,2-A]PYRAZINE

3-BROMOIMIDAZO[1,2-A]PYRAZINE

Basic information Safety Supplier Related

3-BROMOIMIDAZO[1,2-A]PYRAZINE Basic information

Product Name:
3-BROMOIMIDAZO[1,2-A]PYRAZINE
Synonyms:
  • 3-BROMOIMIDAZO[1,2-A]PYRAZINE
  • IMidazo[1,2-a]pyrazine, 3-broMo-
  • 6-methyl-2-phenyl-4-pyrimidinethiolate
  • 3-Bromoimidazo[1,2-a]pyrazine3-Bromoimidazo[1,2-a]pyrazine
  • 3-BROMOIMIDAZO[1,2-A]PYRAZINE ISO 9001:2015 REACH
  • 3-Bromoimidazo[1,2-a]pyrazine
CAS:
57948-41-1
MF:
C6H4BrN3
MW:
198.02
Product Categories:
  • Building Blocks
  • Halogenated Heterocycles
  • Heterocyclic Building Blocks
  • Pyrazines
  • PyrazinesHeterocyclic Building Blocks
Mol File:
57948-41-1.mol
More
Less

3-BROMOIMIDAZO[1,2-A]PYRAZINE Chemical Properties

Melting point:
191-196 °C
Density 
1.89±0.1 g/cm3 (20 ºC 760 Torr)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
pka
1.35±0.30(Predicted)
form 
powder
color 
Faint to light beige
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-37/38-41
Safety Statements 
26-36/37
WGK Germany 
3
HS Code 
2933998090
More
Less

3-BROMOIMIDAZO[1,2-A]PYRAZINE Usage And Synthesis

Synthesis

274-79-3

57948-41-1

The general procedure for the synthesis of 3-bromoimidazo[1,2-A]pyrazines from indolo[1,2-A]pyrazines was as follows: imidazo[1,2-α]pyrazines (90 mg, 0.76 mmol) and sodium acetate (75 mg, 0.91 mmol) were dissolved in methanol (2 mL) saturated with potassium bromide and the mixture was cooled to -10 °C. Subsequently, bromine (121 mg, 0.76 mmol) was slowly added dropwise over 5 min. After the dropwise addition was completed, 1N sodium sulfite solution (2 mL) was added to terminate the reaction, followed by removal of the solvent under vacuum. The residue was dissolved in a mixture of water (15 mL) and saturated sodium bicarbonate solution (15 mL) and extracted with ethyl acetate (2 x 40 mL). The organic phases were combined, washed with brine (40 mL), dried over anhydrous sodium sulfate and the solvent evaporated to give 3-bromoimidazo[1,2-α]pyrazine (150 mg, 100% yield) as a white crystalline solid. The NMR hydrogen spectrum (400 MHz, CDCl3) data were as follows: δH 7.80 (1H, s), 6.87 (1H, d, J=7 Hz), 7.71 (1H, s), 8.27 (1H, d, J=7 Hz).

References

[1] Patent: US2004/19057, 2004, A1. Location in patent: Page/Page column 9
[2] Tetrahedron, 2011, vol. 67, # 47, p. 9063 - 9066
[3] Patent: WO2010/125101, 2010, A1. Location in patent: Page/Page column 50
[4] Patent: CN104341425, 2018, B. Location in patent: Paragraph 0169; 0171; 0174; 0175

3-BROMOIMIDAZO[1,2-A]PYRAZINESupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com